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INTRODUCTION METHODS
Asthma is an inflammatory disease associated with chronic perturbation of 
homeostatic mechanisms, leading to alterations in the structure of the airway walls, 
termed airway remodeling (AR).  Lung fibrosis is characterized by increased 
deposition of extracellular matrix (ECM) proteins, especially collagens, and 
enhanced proliferation and activation of fibroblasts, and, ultimately, distortion of 
normal lung architecture and loss of respiratory function.  
L-arginine is a key precursor of nitric oxide and proline, an amino acid enriched in 
collagen.  ArgII, which converts L-arginine into L-ornithine and urea, is a key enzyme 
of the urea cycle in the liver, but it is also expressed in cells and tissues that lack a 
complete urea cycle, including the lung.  Arg II exists as two distinct isoenzymes, 
Arg I and II, which are encoded by different genes. Arg I isoenzyme is a cytosolic 
enzyme and is the predominant isoform in the liver, where it is highly expressed [3].  
Even though low levels Arg II have been detected in liver as well [4], this 
mitochondrial enzyme is mainly expressed in extrahepatic tissue [3].
Arginase isoenzymes and the downstream enzymes ODC and OAT are key regulators 
of critical processes associated with asthma including AR, cell hyperplasia and 
collagen deposition and have been implicated in the hyperplastic and fibrotic 
changes of AR, respectively.
One of the biological functions of Arg II may be regulation of the synthesis of nitric 
oxide (NO) by means of competition with NO synthase (NOS) for the common 
substrate, L-arginine (Figure 1). In addition, extrahepatic may be involved in tissue 
repair processes through the synthesis of L-ornithine.  Thus, L-ornithine is a 
precursor of polyamines and L-proline, which are involved in cell proliferation and 
collagen synthesis, respectively [3, 5].
Acetylsalicylic acid (ASA) or aspirin is a compound commonly used to treat a variety 
of medical issues, such as pain and inflammation. ASA interacts with COX-1 and COX-
2 enzymes to suppress prostaglandins (PG) and thromboxanes (THX), as well as 
produce more NO-radicals to decrease inflammation [6].  ASA can act as a trigger for 
aspirin-induced asthma or asthma-exacerbated respiratory disease (AERD). AERD is 
thought to occur due to aspirin’s blocking of COX-1 activity [7]. The resulting 
decrease in PG, THX and overproduction of inflammation-causing leukotrienes result 
in increased asthma and allergy-like symptoms.
RESULTSABSTRACT
Airway remodeling (AR) in asthma is characterized by increased airway smooth 
muscle mass, sub-epithelial fibrosis, epithelial changes, and increased numbers of 
fibroblasts and myofibroblasts [1].  Established AR is resistant to current asthma 
therapies and can lead to irreversible airflow limitation, thereby increasing the 
severity of asthma [2].  We hypothesized that L-arginine metabolism is altered in AR, 
ultimately affecting collagen synthesis which may be evidenced by upregulation of 
expression of genes involved in arginine metabolism.  We investigated expression 
levels of key regulatory enzymes in the arginine pathway: I (Arg I),  (Arg II), 
ornithine decarboxylase (ODC), and ornithine aminotransferase (OAT).  mRNA levels 
were detected by reverse-transcriptase quantitative polymerase chain reaction (RT-
qPCR). Cells were treated with acetylsalicylic acid (ASA), a known trigger of 
symptoms for aspirin-induced asthma, for 24 hrs. ASA upregulated ArgII mRNA 5-fold 
and 7-fold in NHLF and DHLF, respectively after 24 hours. ODC and OAT mRNA were 
not significantly altered by treatment. Cell immunochemistry and/or enzyme-linked 
immunosorbent assay (ELISA) were utilized to identify protein levels in human lung 
fibroblast (HLF) from normal (NHLF) and diseased (DHLF) asthmatic donors.  ELISA 
was performed with nuclear, mitochondrial, and cytosolic protein fractions. Arg I 
mRNA was not detected. Cell immunochemistry experiments indicated Arg II proteins 
were present in NHLF and DHLF with or without ASA treatment. Arg II levels were 
further analyzed via ELISA.  In all of the NHLF and DHLF fractions, there was an 
increase in Arg II after ASA treatment. There was a highly significant relative 
increase in the protein levels (P<0.01) of ArgII after ASA treatment in mitochondria 
in DHLF.  In DHLF, there was an increase in both mRNA and protein levels of Arg II 
increase after 24 hours of ASA treatment.  As Arg II may be involved in airway 
remodeling during the development of asthma, limiting exposure to aspirin may have 
an effect on lowering the rate of airway remodeling, and thus have an effect on 
asthma development.  Further investigation into the role of the pathway in aspirin-
intolerant asthma needs to be pursued.
CONCLUSIONS
ArgII is present in all three extracted fractions and can be detected at higher levels 
after 24-hour treatment of ASA.  ASA increased both mRNA and protein expression of 
ArgII in NHLF as well as in DHLF after 24 hours.  However, this increase was highly 
significant in the mitochondrial fractions of ArgII. 
These data suggest that it may be possible to decrease airway remodeling in asthma 
development by limiting exposure to aspirin.
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Cell Culture
Normal and diseased asthmatic human lung fibroblasts were purchased from Lonza. 
Cells were cultured in Dulbecco’s Modified Eagle Medium (Cellgro) containing 10% 
FBS. Passages 2-15 were used. 
Cell Lysis and Protein Quantification
1 x 106 cells were added to 100 mm plates for 24h at 37°C, cells were treated or not 
treated with 10 mM acetylsalicylic acid (Sigma-Aldrich). After 24h incubation at 
37°C, cells were scraped and collected. Cells were lysed with Mitochondrial 
Extraction Kit (Novus). Protein concentrations were quantified using the Pierce BCA 
Protein Assay Kit. Concentrations were measured at 540 nm.
Cell Staining
2.5 x 105 cells were added to plate wells containing EtOH-washed glass coverslips. 
After 24h, cells were treated or not treated with 10 mM acetylsalicylic acid. After 
48h incubation at 37°C, cells were washed with serum-free DMEM. Cells were then 
incubated with MitoTracker Orange CM-H2TMRos (Invitrogen) for 15 min at 37°C. Cells 
were then fixed for 30 min at RT with CytoFix (BD). Cells were washed with 1X PBS 
and left to sit in PBS ON at 4°C. 1X PermWash (BD) was then added to cells for 30 
min at RT. Primary antibody in PermWash was added to cells, which were then 
covered and incubated at 37°C for 2h. Primary antibodies used were against ArgII
and OAT. Cells were kept ON at 4°C. Cells were washed with 1X PBS. Cells were then 
treated with PermWash and secondary antibody (Invitrogen AlexaFluor 488) for 2h at 
37°C. Cells were washed with 1X PBS. Glass slides were labelled, and EMS DAPI 
FluoroGel II was added to the slides. Coverslips were flipped onto the Fluorogel and 
sealed with clear nail polish. Slides were examined using confocal microscopy 
utilizing 360 nm, 488 nm, and 554 nm wavelengths to view nuclei, protein of 
interest, and mitochondria, respectively. 
ELISA
ELISA was performed using the Enzyme-linked Immunosorbent Assay Kit for Arg II 
from MyBioSource.com, a sandwich-style ELISA.  Nuclear, mitochondrial, and 
cytosolic fractions were tested. 50 μg of protein lysate was analyzed in duplicate. 
Samples were first incubated in antibody-treated wells for 1h at 37°C. Wells were 
then incubated with the first detection reagent 1h at 37°C, washed, and incubated 
with a second detection reagent 30 min 37°C. After more washes, substrate was 
added to the wells, and the wells were incubated 20 min at 37°C. Stop Reagent was 
added, and the wells were quantified immediately at 450 nm.  Assay was performed 
with five biological replicates. 
RT-PCR
Reverse Transcriptase Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR)
RNA was extracted from HLF using the RNeasy Micro kit (Qiagen, Valencia, CA). 5 μg
of RNA was used to synthesize complementary DNA (cDNA) using the Superscript II 
Reverse Transcriptase kit (Invitrogen, Life Technologies, Carlsbad, CA) according to 
the manufacturer’s instructions for cDNA synthesis using random primers. Random-9-
mer primers were purchased from Agilent Technologies (New Castle, DE). cDNA was 
diluted 5x prior to qPCR. qPCR was conducted using the Premix Ex Taq Perfect Real-
Time kit (Clontech Laboratories, Takara Bio, Mountain View, CA) and Taqman Gene 
Expresssion Assay probes (Applied Biosystems, Life Technologies, Carlsbad, CA) for 
GAPDH (Hs02758991_g1), Arg 1 (Hs00968979_m1), Arg II (Hs00982833_m1), ODC 
(Hs00159739_m1) and OAT (Hs00236852_m1). Reactions were performed in triplicate 
using the ABI Prism 7000 Sequence Detection System under the following thermal 
cycling conditions: initial denaturation at 95 °C for 2 minutes followed by 40 cycles 
of 95 °C for 5 seconds and 60 °C for 37 seconds. Data were normalized using GAPDH 
as an endogenous control. The comparative Ct method was used to determine fold-
change in mRNA levels relative to untreated control samples.
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(A) NHLF                                           (B) DHLF
Figure 2: The Effects of ASA on ARG2 mRNA Expression in HLF. ARG II 
mRNA expression was assessed in NHLF (A) and DHLF (B). HLF were treated 
with 10 mM ASA and 1 μM RvD1 for 24 hours. RNA was then extracted from 
and analyzed by RT-qPCR.  Data were statistically analyzed using 
randomized block ANOVA, followed by Tukey’s multiple comparisons test.  
Depicted are the mean relative mRNA levels ± SEM for n = 3 biological 
replicates performed in triplicate for all experiments for which n =4 
biological replicates were performed in triplicate. Stars indicate significant 
differences determined using Tukey’s multiple comparisons test as follows: 











Figure 3: Cellular localization of ArgII in NHLF or DHLF, untreated or treated with 
10 mM acetylsalicylic acid (ASA) for 24h. Immunohistochemical detection of the 
protein shown in green. Nuclei counterstained with 4’6-diamidino-2-phenlindole 
(DAPI) shown in blue. Mitochondria counterstained with MitoTracker Orange (CM-
H2TMRos).  All three stains superimposed (merged).
Figure 4: ELISA detection of II in nuclear, mitochondrial, and 
cytosolic fractions of NHLF or DHLF.  Relative Levels of Arg II 
isoenzyme were detected via ELISA in treated HLF cells in presence of 
10 mM acetylsalicylic acid (ASA) for 24h compared to control.   Data 
were statistically analyzed using student t-test.  Depicted are the mean 
relative protein levels ± SEM for n = 3 biological replicates performed in 















































24h ASA Treatments of Normal and Asthmatic 
Human Lung Fibroblast
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